Krebs Biochemicals & Industries Ltd (KREBSBIO) — Board Meeting | 29 September 2026

29 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

34th AGM approved FY2026 audited financials and reappointed directors.

🔄 What Changed

Reappointment of directors Dr. R T Ravi and Manish Kumar Jain.

🔮 What's Next

None

💡 Investor Takeaway

Routine procedural filing with no direct impact on shareholders.

Krebs Biochemicals & Industries held its 34th AGM on September 29, 2026 via video conference, approving the audited financials for FY2026, reappointing directors Dr. R T Ravi and Manish Kumar Jain, and endorsing related party transactions with Ipca Laboratories and cost auditor remuneration. Shareholders participated through electronic voting, with results to be posted online after scrutiny.

📄 View Original Announcement (PDF)

📊 Stock Analysis — KREBSBIO ✨ Ask AI About This

About Krebs Biochemicals & Industries Ltd (KREBSBIO)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹121.84 CrROE: 8.7%ROCE: -10.9%

View full KREBSBIO stock details →

📡 Get AI alerts when KREBSBIO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track KREBSBIO — Free

💡 Ask AI about this filing

"How did shareholders vote on director reappointments?""What were the related party transaction terms with Ipca?""When will the e-voting results be published?"

Ask AI Free →

📊 More KREBSBIO filings

Announcement — 21 September 2026Krebs Biochemicals & Industries Ltd announced that its trading window will close on September 30, 20...
🟡 Board Meeting — 4 September 2026Krebs Biochemicals & Industries Limited announced its 34th Annual General Meeting (AGM) to be held o...
🔴 Annual Report — 4 September 2026Krebs Biochemicals & Industries Limited reported a consolidated net loss of ₹1,693.31 Lakhs for FY 2...
🟡 Board Meeting — 6 August 2026The board approved unaudited Q1 FY26 results and a limited auditor review, confirming financials for...
share transfer — 2 July 2026Krebs Biochemicals & Industries Limited received SEBI-mandated certificates from its share transfer ...

See all KREBSBIO filings →

🔥 Also filed on 29 September 2026

ADANIENTAdani Enterprises LtdAnnouncement APOLLOApollo Micro Systems LtdAnnouncement ADANIPORTSAdani Ports & Special Economic Zone LtdAnnouncement ADANIPOWERAdani Power LtdAnnouncement PFOCUSPrime Focus LtdAnnouncement MCXMulti Commodity Exchange of India LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when KREBSBIO files new disclosures

Track KREBSBIO filings, board meetings, and corporate actions. Free email alerts at 5 PM.